ProShares UltraShort NASDAQ Biotechnology
9 hedge funds and large institutions have $4.07M invested in ProShares UltraShort NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$543K | |
| 2 | +$331K | |
| 3 | +$273K | |
| 4 |
HF
HRT Financial
New York
|
+$258K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$112K |
Top Sellers
| 1 | -$426K | |
| 2 | -$376K | |
| 3 | -$7.56K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$5K |